Cabaletta Bio logo

Cabaletta Bio

CABA | NASDAQ
Chart Builder DCF Calculator
$1.11
-$0.17 (-13.28%)
At close: Nov 16, 2026, 4:00 PM ET
$1.13
+$0.02 (+1.83%)
After-hours: Nov 16, 2026, 7:43 PM ET
-13.28%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
30
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #791/1021 (Top 77%)

Key Statistics

Market Data

Market Cap $239.45M
1D Range
1.10 1.26
52W Range
1.10 4.15

Valuation (TTM)

PE -0.78
PB 0.84
EV/EBITDA 0.20

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $14.00
Loading financial charts...

Profile

Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat ...

Sector Healthcare
Industry Biotechnology
Employees 156
IPO Date Oct 25, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$14.00
Upside
+1161.26%
Buy (5)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.